Sep 10, 2026 06:48AM
Sep 1, 2026 06:59AM
Aug 13, 2026 07:41AM
Aug 13, 2026 07:30AM
Aug 6, 2026 04:01PM
May 7, 2026 07:40AM
May 7, 2026 07:30AM Ascendis Pharma Reports First Quarter 2026 Financial Results
Apr 30, 2026 04:01PM
Mar 31, 2026 08:00AM
Feb 11, 2026 04:01PM
Feb 11, 2026 04:01PM
Feb 4, 2026 04:01PM
Jan 9, 2026 06:01PM
Jan 8, 2026 08:49AM 4Q25/2026 Biotech Earnings Preview: RBC
Nov 16, 2025 03:00PM
Nov 13, 2025 04:04AM
Nov 12, 2025 04:05PM
Nov 12, 2025 04:01PM
Nov 5, 2025 04:01PM
Oct 12, 2025 03:00PM
Sep 15, 2025 11:50AM Top 3 Biotech Stocks to Watch According to BofA Global Research
Aug 8, 2025 05:29AM
Aug 7, 2025 04:04PM
Aug 7, 2025 04:01PM
Jul 31, 2025 04:01PM
Jun 10, 2025 06:32AM
May 25, 2025 03:00PM
May 1, 2025 04:01PM Ascendis Pharma (ASND) Misses Q1 EPS by 11c
May 1, 2025 04:01PM
Apr 24, 2025 04:01PM
Apr 2, 2025 07:04AM
Feb 25, 2025 09:24AM
Feb 15, 2025 10:00PM
Feb 12, 2025 04:01PM
Feb 11, 2025 06:48AM Cantor Fitzgerald Reiterates Overweight Rating on Ascendis Pharma (ASND)
Feb 5, 2025 04:01PM
Nov 15, 2024 07:10AM
Nov 14, 2024 04:04PM
Nov 14, 2024 04:01PM
Nov 7, 2024 04:01PM
Oct 21, 2024 08:26AM
Sep 4, 2024 04:57AM Ascendis Pharma (ASND) PT Lowered to $178 at Citi
Sep 3, 2024 05:15PM
Sep 3, 2024 05:04PM
Aug 28, 2024 08:30AM
Aug 21, 2024 06:21AM
May 2, 2024 04:01PM
Apr 25, 2024 04:46PM
Feb 7, 2024 04:47PM Ascendis Pharma (ASND) Tops Q4 EPS by 37c
Feb 7, 2024 04:01PM

1,231,050 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All